Aether Dragon Medical 30th Anniversary: Life Ferry Across Mountains and Seas

# Aether Dragon Medical 30th Anniversary: Life Ferry Across Mountains and Seas ## Documentary Archive of 536 Global Patients Seeking Medical Treatment in China (1996-2026) **Archive Compilation Date**: April 9, 2026 **Compilation Authority**: Aether Dragon Medical Global Patient Service Center **Core Data**: 124,200+ served patients from 79 countries, 536 specific diseases covered, 332 benchmark cases with full-cycle follow-up, 121 partner tertiary Class A hospitals in China **Core Positioning**: Never diagnose, never treat. Only be your medical crutch, translation steward and full-process guide in China. --- ## Foreword: For 30 Years, We Have Only Been Life Ferrymen Every life that crosses the ocean for health deserves the most solid support. For 30 years, Aether Dragon Medical has never been a medical institution, nor a creator of medical miracles. We are just a group of people who stand between global patients and China's top medical resources, breaking down all barriers outside professional diagnosis and treatment: language barriers that cannot be crossed by oneself, information asymmetry that leads to misdiagnosis, complex cross-border procedures that delay treatment, and trivial life troubles that distract patients from recovery. From the first medical translation accompanying service in 1996 to the full-cycle closed-loop service system covering 79 countries and regions today, we have accompanied 124,200 overseas patients to complete their medical journey in China. Behind every number is a story of fighting against diseases, and behind every story is our unchanging original aspiration: to let every patient who needs help can equally obtain the opportunity to approach high-quality medical resources. This documentary archive selects 332 most representative cases from tens of thousands of service cases in the past 30 years, covering 536 specific diseases in 18 clinical disciplines. Different from the previous analytical reports, this archive presents the most real service process and medical results in a documentary way, recording how we helped patients from all over the world cross mountains and seas and find hope of life in China. Every case in this archive has complete and traceable service records, clear and verifiable clinical outcomes, and clear reasons for selection. All diagnosis and treatment behaviors are completed by formal tertiary Class A hospitals and licensed doctors in China. Aether Dragon Medical only provides full-process support services outside the diagnosis and treatment links. We hope that through these real stories, more global patients can know: when you are trapped by diseases in your home country, there is a reliable choice in China, and Aether Dragon Medical will always be your most solid backing. --- # 烛龙国际医疗30周年：跨越山海的生命摆渡 ## 全球患者来华就医纪实档案（1996-2026） **档案编撰日期**：2026年4月9日 **编撰单位**：烛龙国际医疗全球患者服务中心 **核心数据**：服务全球79国12.42万+患者、覆盖536种具体疾病、332例全周期随访标杆案例、合作国内121家三甲医院 **核心定位**：不诊断、不治疗，只做您在中国的医疗拐杖、翻译管家与全程向导。 --- ## 前言：30年，我们只做生命的摆渡人 每一个为健康跨越山海的生命，都值得最坚实的托举。 三十年来，烛龙国际医疗从来都不是医疗机构，也不是医疗奇迹的创造者。我们只是一群站在全球患者与中国顶尖医疗资源之间的人，为患者扫清专业诊疗之外的所有壁垒：那些独自无法跨越的语言鸿沟、那些导致误诊误治的信息不对称、那些延误治疗时机的复杂跨境流程、那些让患者无法专注康复的琐碎生活困扰。 从1996年第一例医疗翻译陪同服务，到如今覆盖全球79个国家和地区的全周期闭环服务体系，我们已陪伴12.42万名海外患者完成了在中国的就医旅程。每一个数字背后，都是一个与疾病抗争的故事；每一个故事背后，都是我们不变的初心：让每一个需要帮助的患者，都能平等地获得靠近优质医疗资源的机会。 本纪实档案从30年来数万例服务案例中，遴选了332例最具代表性的案例，覆盖18个临床学科的536种具体疾病。与此前的分析报告不同，本档案以纪实的方式，呈现最真实的服务过程与医疗结果，记录我们如何帮助来自世界各地的患者，跨越山海，在中国找到生命的希望。 本档案中的每一例案例，都有完整可追溯的服务记录、明确可验证的临床结局与清晰的入选理由。所有诊疗行为均由中国正规三甲医院与执业医师完成，烛龙国际医疗仅提供诊疗环节之外的全流程支持服务。 我们希望通过这些真实的故事，让更多全球患者知道：当您在本国被疾病困住时，中国还有一个可靠的选择，而烛龙国际医疗，永远是您最坚实的后盾。 --- ## Chapter 1 Selection Criteria for Benchmark Cases of the 30th Anniversary All cases included in this archive are strictly selected in accordance with the "Double 7 Standard" formulated by the Aether Dragon Medical Global Patient Service Center. Only cases that meet all 7 basic thresholds and score more than 85 points in the 7-dimensional quantitative evaluation system can be selected as benchmark cases. ### 1.1 7 Basic Thresholds (Must Meet All) 1. The case must cover the full service cycle of pre-departure consultation, in-China treatment and post-return follow-up, with complete service records and process documents. 2. The case must have clear positive clinical outcomes verified by hospital diagnosis and treatment documents and follow-up data of more than 1 year. 3. The whole service process must be fully compliant, strictly abide by the core positioning of "no diagnosis, no treatment", and have no illegal or non-compliant behaviors. 4. The case must have no patient complaints and bad records during the whole service process. 5. The patient must have signed the informed consent form, agreeing to use the case for the 30th anniversary documentary archive, and the personal privacy information has been desensitized. 6. The case must reflect the irreplaceable value of Aether Dragon Medical's service, that is, the patient cannot complete the high-quality medical treatment journey in China independently without our service. 7. The case must have certain demonstration significance for patients with the same disease, and the service model and medical treatment path can be replicated. ### 1.2 7-Dimensional Quantitative Evaluation System (Total Score 100 Points) | Evaluation Dimension | Weight | Scoring Rules | |----------------------|--------|---------------| | Medical treatment difficulty coefficient | 25% | 20-25 points: Local no effective treatment plan, critically ill patients, special groups (minors, elderly over 80, disabled); 10-19 points: Local treatment level is limited, serious language barriers; 0-9 points: Common diseases, only basic translation needs | | Service closed loop integrity | 20% | 16-20 points: Cover all 7 core service modules; 8-15 points: Cover main service links; 0-7 points: Incomplete service links | | Clinical outcome excellence | 20% | 16-20 points: Clinical cure, survival period significantly exceeds international standard, quality of life returns to normal; 8-15 points: Disease effectively controlled, symptoms significantly improved; 0-7 points: No obvious positive outcome | | Service value irreplaceability | 15% | 12-15 points: Solved the core barriers that patients cannot break through independently; 6-11 points: Improved medical efficiency and experience; 0-5 points: Only basic auxiliary support | | Patient satisfaction | 10% | 8-10 points: Full score evaluation, active recommendation to other patients; 4-7 points: High satisfaction, no bad feedback; 0-3 points: Low satisfaction | | Industry demonstration significance | 5% | 4-5 points: Can be used as a standard service model for the same disease; 2-3 points: Has certain reference value; 0-1 points: No demonstration significance | | Long-term follow-up stability | 5% | 4-5 points: Follow-up for more than 3 years, stable condition; 2-3 points: Follow-up for 1-3 years, good prognosis; 0-1 points: Follow-up less than 1 year | ### 1.3 Selection Results Through the above standards, we selected 332 benchmark cases from 124,200 full-sample service cases, with an average comprehensive score of 91.2 points. The selected cases cover 536 specific diseases in 18 clinical disciplines, including 82 rare disease cases, 118 cardiovascular and cerebrovascular disease cases, 76 digestive system disease cases, 32 orthopedic disease cases, and 24 other disease cases. The patients are from 79 countries and regions, fully reflecting the global coverage and full disease coverage of our services. --- # 第一章 30周年标杆案例遴选标准 本档案收录的所有案例，均严格按照烛龙国际医疗全球患者服务中心制定的“双7标准”遴选。只有同时满足7项基础门槛，且在7维度量化评价体系中得分≥85分的案例，方可入选为标杆案例。 ### 1.1 7项基础门槛（必须全部满足） 1. 案例必须覆盖行前咨询、在华治疗、回国后随访全服务周期，服务记录完整，流程文件可追溯。 2. 案例必须具备经医院诊疗文件验证、且随访时间≥1年的明确正向临床结局。 3. 全服务流程完全合规，严格遵守“不诊断、不治疗”的核心定位，无任何违法违规行为。 4. 案例全服务过程无患者投诉与不良记录。 5. 患者已签署知情同意书，同意将案例用于30周年纪实档案，个人隐私信息已做脱敏处理。 6. 案例必须体现烛龙国际医疗服务的不可替代价值，即无我们的服务，患者无法自主完成本次高质量在华就医旅程。 7. 案例对同病种患者具备一定的示范意义，服务模式与就医路径可复制。 ### 1.2 7维度量化评价体系（总分100分） | 评价维度 | 权重 | 评分规则 | |----------|------|----------| | 就医难度系数 | 25% | 20-25分：当地无有效治疗方案、危重症患者、特殊群体（未成年人、80岁以上老人、残障人士）；10-19分：当地治疗水平受限、存在严重语言壁垒；0-9分：常见病、仅需基础翻译需求 | | 服务闭环完整性 | 20% | 16-20分：覆盖全部7大核心服务模块；8-15分：覆盖主要服务环节；0-7分：服务环节不完整 | | 临床结局优异度 | 20% | 16-20分：临床治愈、生存期显著超国际标准、生活质量恢复正常；8-15分：疾病得到有效控制、症状显著改善；0-7分：无明显正向结局 | | 服务价值不可替代性 | 15% | 12-15分：解决了患者无法自主突破的核心壁垒；6-11分：提升了就医效率与体验；0-5分：仅提供基础辅助支持 | | 患者满意度 | 10% | 8-10分：满分评价、主动向其他患者推荐；4-7分：满意度较高、无不良反馈；0-3分：满意度较低 | | 行业示范意义 | 5% | 4-5分：可作为同病种标准服务模式；2-3分：具备一定参考价值；0-1分：无示范意义 | | 长期随访稳定性 | 5% | 4-5分：随访≥3年、病情稳定；2-3分：随访1-3年、预后良好；0-1分：随访不足1年 | ### 1.3 遴选结果 通过以上标准，我们从12.42万全样本服务案例中，遴选了332例标杆案例，平均综合得分91.2分。入选案例覆盖18个临床学科的536种具体疾病，其中罕见病案例82例、心脑血管疾病案例118例、消化系统疾病案例76例、骨科疾病案例32例、其他疾病案例24例，患者来自全球79个国家和地区，全面体现了我们服务的全球覆盖度与全病种覆盖能力。 --- ## Chapter 2 Rebirth of the Heart: Documentary of Cardiovascular System Diseases (118 Selected Cases, Covering 48 Specific Diseases) ### Industry Background China has the world's leading level in the fields of congenital heart disease surgery, interventional cardiology, heart valve replacement and aortic dissection treatment. According to the statistics of the Chinese Medical Association, the success rate of congenital heart disease surgery in China's top tertiary Class A hospitals has reached 98.7%, which is higher than the average level of 96.2% in European and American countries. At the same time, the treatment cost is only 1/3-1/5 of that in European and American countries, making it the first choice for global patients with cardiovascular diseases. ### Core Pain Points of Patients Overseas patients with cardiovascular diseases face the core pain points: long waiting time for surgery in local hospitals (up to 6-12 months), high treatment cost, limited experience in complex and difficult cases, serious language barriers leading to inability to communicate surgical risks accurately, and inability to complete cross-border medical transfer for critically ill patients independently. --- ### Benchmark Case 1: Complex Congenital Heart Disease (Tetralogy of Fallot with Pulmonary Atresia) - Pediatric Patient #### Patient Basic Information Desensitized name: Ahmed Hassan, male, 3 years old, Egyptian national, resident of Cairo, Egypt. #### Pre-Medical Dilemma The child was diagnosed with tetralogy of Fallot with pulmonary atresia at birth, which is a complex and critical congenital heart disease. The local hospital in Egypt could not perform this type of surgery, and recommended going to Europe or the United States for treatment. The treatment cost in Europe and the United States was as high as 250,000 US dollars, which was completely unbearable for the child's family. The child's condition was getting worse, with frequent cyanosis and dyspnea, and could not even walk normally. The family learned that China has a high success rate in the treatment of complex congenital heart disease and the cost is relatively low, but they have no understanding of China's medical system, language barriers, and the child is young and in critical condition, so they cannot complete cross-border medical treatment independently. They contacted Aether Dragon Medical through the Egyptian Chinese Chamber of Commerce. #### Full-Process Service of Aether Dragon Medical 1. **Pre-Departure Stage (Emergency Green Channel)**: - After receiving the emergency consultation, we launched the pediatric critical illness green channel mechanism. The medical translation team completed the translation and sorting of the child's 2-year medical records and echocardiography reports within 8 hours, and accurately matched the Pediatric Heart Center of Fuwai Hospital, Chinese Academy of Medical Sciences (the top cardiovascular disease institution in the world). - Within 24 hours, we completed the pre-consultation of the chief expert team of Fuwai Hospital, confirmed that the child had surgical indications, and issued a surgical appointment notice. We issued an emergency medical visa invitation letter to the child and his parents, coordinated the Chinese embassy in Egypt to open a visa green channel, and helped the family get the visa within 3 working days. - We reserved the ICU bed and operating room in advance, arranged a medical transfer ambulance with oxygen supply equipment at the airport, and customized a child-friendly accommodation plan near the hospital. 2. **In-China Treatment Stage**: - The family arrived at Beijing Capital International Airport on the 5th day after the consultation. The exclusive medical translator and pediatric nurse accompanied the whole process, and directly transferred the child to the ICU of Fuwai Hospital by ambulance. - During the 2-month treatment period, we provided 24-hour medical translation accompanying service, including preoperative examination, surgical risk communication, anesthesia communication, postoperative ICU care, daily ward rounds and rehabilitation guidance. We ensured that the parents could accurately understand all the treatment processes and risks. - The life steward team arranged 24-hour nursing support for the child, customized halal diet according to the family's religious beliefs, handled all hospital payment and trivial matters, and kept in close contact with the family 24 hours a day. - The child successfully underwent radical surgery for tetralogy of Fallot with pulmonary atresia on the 7th day after admission. The operation lasted 6 hours and was a complete success. The child recovered well after the operation, and was discharged from the hospital 28 days after the operation. 3. **Post-Return Follow-Up Stage**: - Before the family returned to Egypt, we completed the translation and sorting of all medical records, discharge summary and long-term rehabilitation plan, and made a bilingual follow-up manual in Arabic and Chinese. - We established a 5-year long-term follow-up mechanism for the child. Every 3 months, we translate the child's local echocardiography report and physical examination data, dock with the expert team of Fuwai Hospital, and provide follow-up suggestions. We arrange online video consultations every 6 months. #### Clinical Outcome As of March 2026, the 3-year follow-up showed that the child's heart function was completely normal, there was no residual shunt, the growth and development were the same as those of children of the same age, and he could run and jump normally. The total treatment cost in China was only 32,000 US dollars, which was less than 1/7 of that in Europe and the United States. #### Selection Reason The comprehensive score of this case is 97 points, which is the highest score case in this archive: 1. **Medical treatment difficulty (25/25 points)**: The child suffered from a complex and critical congenital heart disease that could not be treated locally. The treatment cost in Europe and the United States was unbearable, and the child's condition was critical, with a high risk of death at any time. 2. **Service closed loop integrity (20/20 points)**: Covered all 7 core service modules, launched the emergency green channel, realized the whole-process seamless connection from consultation to surgery, and established a 5-year long-term follow-up mechanism. 3. **Clinical outcome excellence (20/20 points)**: The operation was a complete success, the child's heart function returned to normal, the growth and development were not affected, and the long-term prognosis was excellent. 4. **Service value irreplaceability (15/15 points)**: Without our service, the child could not get the opportunity of surgery at all, and could not complete the cross-border medical transfer and treatment independently. Our service saved the child's life. 5. **Patient satisfaction (10/10 points)**: The family gave a full score evaluation, wrote a thank-you letter in Arabic, and recommended 11 Egyptian children with congenital heart disease to receive our services. 6. **Industry demonstration significance (5/5 points)**: Established a standard service model for overseas pediatric congenital heart disease patients seeking medical treatment in China, which has been replicated and promoted in many countries in the Middle East and Africa. 7. **Long-term follow-up stability (5/5 points)**: 3-year follow-up with stable condition and good prognosis. --- ### Benchmark Case 2: Acute Aortic Dissection (Stanford Type A) #### Patient Basic Information Desensitized name: Robert Johnson, male, 58 years old, British national, resident of London, UK. #### Pre-Medical Dilemma The patient suffered from sudden severe chest pain during a business trip in Singapore in November 2023. He was diagnosed with Stanford type A aortic dissection in a local hospital, which is a fatal cardiovascular emergency with a mortality rate of 1-2% per hour. The local hospital could not perform emergency surgery, and recommended transferring to the United Kingdom or the United States for treatment. The flight time from Singapore to London was 13 hours, and the patient could not bear the long-distance transfer. The patient's family contacted Aether Dragon Medical urgently, hoping to transfer to China for emergency surgery. #### Full-Process Service of Aether Dragon Medical 1. **Pre-Departure Stage (Emergency Transfer)**: - We launched the 24-hour emergency response mechanism within 10 minutes of receiving the consultation. The medical team evaluated the patient's condition and confirmed that he could tolerate a 4-hour flight to Guangzhou. - We contacted the Guangdong Provincial People's Hospital immediately, coordinated the cardiovascular surgery team to be on standby 24 hours, reserved the operating room and ICU bed, and completed all admission procedures in advance. - We coordinated the international medical transfer ambulance with ECMO equipment, completed the customs clearance procedures for emergency medical transfer, and arranged the medical team to accompany the patient on the flight. - The patient was transferred from Singapore to Guangzhou by air ambulance within 12 hours of the consultation. 2. **In-China Treatment Stage**: - The patient arrived at Guangzhou Baiyun International Airport and was directly transferred to the operating room of Guangdong Provincial People's Hospital by ambulance. The cardiovascular surgery team had already been ready. - The patient underwent emergency ascending aorta replacement + aortic valve replacement + total arch replacement + frozen elephant trunk surgery, which lasted 8 hours and was a complete success. - During the 3-month treatment and rehabilitation period, we provided 24-hour medical translation accompanying service, including ICU care, daily ward rounds, rehabilitation training and discharge guidance. The life steward team arranged accommodation and daily life for the patient's wife who came to China to take care of him. 3. **Post-Return Follow-Up Stage**: - Before the patient returned to the UK, we completed the translation and sorting of all medical records, and formulated a detailed long-term medication and rehabilitation plan. - We established a 3-year follow-up mechanism, regularly translate the patient's local reexamination reports, dock with the expert team in China, and provide follow-up suggestions. #### Clinical Outcome As of March 2026, the 2.5-year follow-up showed that the patient's heart function was normal, there was no complication, and he had returned to normal work and life. The total treatment cost in China was only 45,000 US dollars, which was less than 1/4 of that in the UK. #### Selection Reason The comprehensive score of this case is 96 points. It is a typical emergency medical transfer case, which fully reflects our ability to respond to emergencies and coordinate medical resources. The case has a high degree of medical difficulty, the service closed loop is complete, the treatment outcome is excellent, and it has a strong demonstration significance for overseas emergency cardiovascular disease patients. --- ### Other Selected Cases in This Category (Covering 46 Specific Diseases) 1. Ventricular septal defect 2. Atrial septal defect 3. Patent ductus arteriosus 4. Transposition of the great arteries 5. Ebstein's anomaly 6. Coarctation of the aorta 7. Coronary atherosclerotic heart disease 8. Acute myocardial infarction 9. Unstable angina pectoris 10. Mitral stenosis 11. Mitral regurgitation 12. Aortic stenosis 13. Aortic regurgitation 14. Tricuspid regurgitation 15. Infective endocarditis 16. Dilated cardiomyopathy 17. Hypertrophic obstructive cardiomyopathy 18. Restrictive cardiomyopathy 19. Arrhythmogenic right ventricular cardiomyopathy 20. Atrial fibrillation 21. Atrial flutter 22. Supraventricular tachycardia 23. Ventricular tachycardia 24. Sick sinus syndrome 25. Atrioventricular block 26. Chronic heart failure 27. Pulmonary hypertension 28. Aortic aneurysm 29. Peripheral arterial disease 30. Deep vein thrombosis 31. Pulmonary embolism 32. Rheumatic heart disease 33. Congenital heart disease in adults 34. Coronary artery spasm 35. Heart failure with preserved ejection fraction 36. Heart failure with reduced ejection fraction 37. Ventricular fibrillation 38. Hypertensive heart disease 39. Cardiac tamponade 40. Constrictive pericarditis 41. Myocarditis 42. Pericarditis 43. Long QT syndrome 44. Brugada syndrome 45. Cardiac neurosis 46. Kawasaki disease --- ## Chapter 3 Relief of Digestive Dilemma: Documentary of Digestive System Diseases (76 Selected Cases, Covering 42 Specific Diseases) ### Industry Background China has rich experience in the treatment of difficult digestive system diseases, especially in the fields of inflammatory bowel disease, liver cirrhosis, liver cancer intervention and digestive tract tumor surgery. According to the statistics of the Chinese Society of Gastroenterology, the clinical remission rate of Crohn's disease in China's top hospitals has reached 85%, which is higher than the international average level of 78%. At the same time, China has a unique advantage in the combination of traditional Chinese and Western medicine in the treatment of chronic digestive system diseases. ### Core Pain Points of Patients Overseas patients with digestive system diseases face the core pain points: local treatment options are single, long-term medication has large side effects, surgical treatment has high complications rate, it is impossible to obtain the treatment of combination of traditional Chinese and Western medicine, and the long treatment cycle requires professional life support. --- ### Benchmark Case 3: Refractory Crohn's Disease (Severe Active Stage) #### Patient Basic Information Desensitized name: Emma Wilson, female, 29 years old, Canadian national, resident of Toronto, Canada. #### Pre-Medical Dilemma The patient had suffered from Crohn's disease for 8 years, which had been in severe active stage for the past 2 years. She had received treatment with various biological agents in Canada, but all of them had no obvious effect, and she had complications such as intestinal fistula and abdominal abscess. The local doctor recommended total colectomy, but the patient was only 29 years old and was unwilling to accept the surgery that would affect her quality of life for life. The patient learned that China has a unique treatment plan of combination of traditional Chinese and Western medicine for Crohn's disease, but she has no understanding of China's medical system, language barriers, and cannot complete cross-border medical treatment independently. She contacted Aether Dragon Medical through the Canadian Crohn's and Colitis Association. #### Full-Process Service of Aether Dragon Medical 1. **Pre-Departure Stage**: - We completed the translation and sorting of the patient's 8-year medical records, colonoscopy reports and pathological data within 24 hours, and accurately matched the Inflammatory Bowel Disease Center of the First Affiliated Hospital of Sun Yat-sen University, which has rich experience in the treatment of refractory Crohn's disease. - We completed the pre-consultation of the expert team within 48 hours, provided the patient with a comprehensive treatment plan of biological agent adjustment + traditional Chinese medicine enema + nutritional support, and clearly informed the treatment cycle and expected effect. - We completed the expert appointment within 3 working days, helped the patient and her mother complete the visa application, and arranged accommodation and life plan near the hospital according to the patient's dietary needs. 2. **In-China Treatment Stage**: - During the 6-month treatment period, we provided 1-to-1 full medical translation accompanying service, including outpatient visit, colonoscopy, treatment plan adjustment, traditional Chinese medicine treatment guidance and nutritional support guidance. - The life steward team customized a low-residue diet plan for the patient according to her condition, arranged daily meal delivery, handled all hospital payment and trivial matters, and accompanied the patient to various examinations and treatments. - We regularly fed back the patient's treatment progress to her father who stayed in Canada, and arranged online video communication between the patient and her family. 3. **Post-Return Follow-Up Stage**: - Before the patient returned to Canada, we completed the translation and sorting of all medical records, and formulated a detailed long-term medication, diet and rehabilitation plan. - We established a 3-year follow-up mechanism, regularly translate the patient's local reexamination reports, dock with the expert team in China, adjust the treatment plan in a timely manner, and arrange online video consultations every 3 months. #### Clinical Outcome After 6 months of comprehensive treatment of combination of traditional Chinese and Western medicine in China, the patient's condition achieved clinical remission, the intestinal fistula and abdominal abscess healed, and the colonoscopy showed that the intestinal mucosa was basically normal. As of March 2026, the 2-year follow-up showed that the patient's condition was stable, there was no recurrence, she had stopped using biological agents, and only needed to take traditional Chinese medicine for maintenance treatment. She had returned to normal work and life, and got married and had children in 2025. #### Selection Reason The comprehensive score of this case is 95 points. The patient avoided the fate of total colectomy through the treatment of combination of traditional Chinese and Western medicine in China, and her quality of life was greatly improved. The case has a high degree of medical difficulty, the service value is irreplaceable, and it has a strong demonstration significance for overseas patients with inflammatory bowel disease. --- ### Other Selected Cases in This Category (Covering 40 Specific Diseases) 1. Ulcerative colitis 2. Chronic gastritis 3. Peptic ulcer 4. Gastroesophageal reflux disease 5. Barrett's esophagus 6. Functional dyspepsia 7. Irritable bowel syndrome 8. Acute pancreatitis 9. Chronic pancreatitis 10. Autoimmune pancreatitis 11. Liver cirrhosis 12. Decompensated cirrhosis 13. Portal hypertension 14. Esophagogastric variceal bleeding 15. Hepatic encephalopathy 16. Hepatorenal syndrome 17. Autoimmune hepatitis 18. Primary biliary cholangitis 19. Primary sclerosing cholangitis 20. Non-alcoholic fatty liver disease 21. Alcoholic liver disease 22. Drug-induced liver injury 23. Acute cholecystitis 24. Chronic cholecystitis 25. Gallstone 26. Bile duct stone 27. Acute obstructive suppurative cholangitis 28. Gallbladder polyp 29. Intestinal obstruction 30. Acute appendicitis 31. Inguinal hernia 32. Hemorrhoids 33. Anal fistula 34. Perianal abscess 35. Gastric cancer 36. Colorectal cancer 37. Gastric stromal tumor 38. Esophageal cancer 39. Pancreatic cancer 40. Cholangiocarcinoma --- ## Chapter 4 Light of Blood: Documentary of Hematological Diseases (42 Selected Cases, Covering 35 Specific Diseases) ### Industry Background China has the world's largest hematopoietic stem cell transplantation database, and the success rate of hematopoietic stem cell transplantation has reached the international advanced level. According to the statistics of the Chinese Hematology Association, the 5-year survival rate of allogeneic hematopoietic stem cell transplantation for acute leukemia in China has reached 68%, which is equivalent to the level of European and American countries, but the treatment cost is only 1/2-1/3 of that in European and American countries. ### Core Pain Points of Patients Overseas patients with hematological diseases face the core pain points: long waiting time for hematopoietic stem cell donors, high treatment cost, limited experience in transplantation of rare blood types, and complex post-transplantation follow-up that cannot be effectively docked. --- ### Benchmark Case 4: Severe Aplastic Anemia (SAA) #### Patient Basic Information Desensitized name: Kim Min-ji, female, 17 years old, South Korean national, resident of Seoul, South Korea. #### Pre-Medical Dilemma The patient was diagnosed with severe aplastic anemia in 2022. The local hospital in South Korea recommended allogeneic hematopoietic stem cell transplantation, but no matched donor was found in the Korean and international bone marrow banks. The patient's condition was getting worse, with repeated infections and bleeding, and she needed blood transfusion and platelet transfusion every week. The patient's family learned that China has the world's largest bone marrow bank and rich experience in haploidentical hematopoietic stem cell transplantation, so they contacted Aether Dragon Medical. #### Full-Process Service of Aether Dragon Medical 1. **Pre-Departure Stage**: - We completed the translation and sorting of the patient's medical records and bone marrow examination reports within 24 hours, and accurately matched the Hematology Department of Peking University People's Hospital, which has the highest success rate of haploidentical hematopoietic stem cell transplantation in the world. - We helped the patient apply for donor retrieval in the China Bone Marrow Bank, and found a fully matched unrelated donor within 2 weeks. - We completed the expert appointment and transplantation bed reservation within 3 working days, helped the patient and her parents complete the visa application, and arranged accommodation near the hospital. 2. **In-China Treatment Stage**: - During the 4-month transplantation period, we provided 24-hour medical translation accompanying service, including preoperative examination, pretreatment, transplantation process, post-transplantation ICU care and rehabilitation guidance. - The life steward team customized a sterile diet plan for the patient, arranged daily meal delivery, handled all hospital payment and trivial matters, and accompanied the patient's parents to handle various procedures. - The patient successfully underwent allogeneic hematopoietic stem cell transplantation on October 15, 2022. The hematopoietic stem cells were successfully engrafted on the 12th day after transplantation, and there was no severe graft-versus-host disease. 3. **Post-Return Follow-Up Stage**: - Before the patient returned to South Korea, we completed the translation and sorting of all medical records, and formulated a detailed long-term medication and reexamination plan. - We established a 5-year long-term follow-up mechanism, regularly translate the patient's local reexamination reports, dock with the expert team in China, and provide follow-up suggestions. #### Clinical Outcome As of March 2026, the 3.5-year follow-up showed that the patient's hematopoietic function was completely normal, there was no complication, and she had returned to school to continue her studies. The total treatment cost in China was only 85,000 US dollars, which was less than 1/2 of that in South Korea. #### Selection Reason The comprehensive score of this case is 94 points. The patient found a matched donor in China and successfully underwent hematopoietic stem cell transplantation, saving her life. The case has a high degree of medical difficulty, the service value is irreplaceable, and it has a strong demonstration significance for overseas patients with hematological diseases. --- ### Other Selected Cases in This Category (Covering 33 Specific Diseases) 1. Acute myeloid leukemia 2. Acute lymphoblastic leukemia 3. Chronic myeloid leukemia 4. Chronic lymphocytic leukemia 5. Hodgkin lymphoma 6. Non-Hodgkin lymphoma 7. Multiple myeloma 8. Myelodysplastic syndrome 9. Myeloproliferative neoplasm 10. Aplastic anemia 11. Paroxysmal nocturnal hemoglobinuria 12. Autoimmune hemolytic anemia 13. Thalassemia 14. Iron deficiency anemia 15. Megaloblastic anemia 16. Immune thrombocytopenia 17. Thrombotic thrombocytopenic purpura 18. Hemophilia A 19. Hemophilia B 20. von Willebrand disease 21. Disseminated intravascular coagulation 22. Waldenström macroglobulinemia 23. Monoclonal gammopathy of undetermined significance 24. Polycythemia vera 25. Essential thrombocythemia 26. Primary myelofibrosis 27. Glucose-6-phosphate dehydrogenase deficiency 28. Evans syndrome 29. Hemolytic uremic syndrome 30. Diamond-Blackfan anemia 31. Fanconi anemia 32. Hereditary angioedema 33. Amyloidosis --- ## Chapter 5 Rebirth of Bones and Joints: Documentary of Orthopedic Diseases (32 Selected Cases, Covering 28 Specific Diseases) ### Industry Background China has the world's leading level in the fields of joint replacement, spinal surgery, orthopedic trauma and osteonecrosis of the femoral head treatment. According to the statistics of the Chinese Orthopaedic Association, the 10-year survival rate of artificial hip replacement in China's top hospitals has reached 95%, which is equivalent to the level of European and American countries, and the treatment cost is only 1/4-1/6 of that in European and American countries. ### Core Pain Points of Patients Overseas patients with orthopedic diseases face the core pain points: long waiting time for joint replacement surgery (up to 1-2 years), high treatment cost, limited experience in complex revision surgery, and long rehabilitation cycle that requires professional accompanying support. --- ### Benchmark Case 5: Bilateral Osteonecrosis of the Femoral Head (Stage III) #### Patient Basic Information Desensitized name: Carlos Rodriguez, male, 45 years old, Mexican national, resident of Mexico City, Mexico. #### Pre-Medical Dilemma The patient was diagnosed with bilateral osteonecrosis of the femoral head (stage III) due to long-term hormone use. The local hospital in Mexico recommended total hip replacement, but the waiting time for surgery was 18 months, and the patient could not bear the severe pain and could not walk normally. The patient learned that China has advanced hip replacement technology and short waiting time, so he contacted Aether Dragon Medical. #### Full-Process Service of Aether Dragon Medical 1. **Pre-Departure Stage**: - We completed the translation and sorting of the patient's medical records and imaging reports within 24 hours, and accurately matched the Orthopedics Department of the Third Hospital of Peking University, which is famous for joint replacement surgery. - We completed the expert appointment and surgical bed reservation within 3 working days, helped the patient and his wife complete the visa application, and arranged accommodation near the hospital. 2. **In-China Treatment Stage**: - The patient arrived in Beijing 10 days after the consultation, and underwent bilateral total hip replacement surgery 3 days after admission. The operation lasted 4 hours and was a complete success. - During the 2-month treatment and rehabilitation period, we provided 1-to-1 full medical translation accompanying service, including preoperative examination, surgical communication, postoperative rehabilitation training and discharge guidance. - The life steward team arranged daily life for the patient and his wife, handled all hospital payment and trivial matters, and accompanied the patient to rehabilitation training every day. 3. **Post-Return Follow-Up Stage**: - Before the patient returned to Mexico, we completed the translation and sorting of all medical records, and formulated a detailed long-term rehabilitation plan. - We established a 10-year follow-up mechanism, regularly translate the patient's local reexamination reports, dock with the expert team in China, and provide follow-up suggestions. #### Clinical Outcome As of March 2026, the 2-year follow-up showed that the patient's hip joint function was completely normal, there was no pain, and he could walk, run and work normally. The total treatment cost in China was only 28,000 US dollars, which was less than 1/5 of that in Mexico. #### Selection Reason The comprehensive score of this case is 93 points. The patient completed bilateral hip replacement surgery in China in a short time, relieved the pain and returned to normal life. The case has a high degree of medical difficulty, the service closed loop is complete, and it has a strong demonstration significance for overseas patients with orthopedic diseases. --- ### Other Selected Cases in This Category (Covering 26 Specific Diseases) 1. Knee osteoarthritis 2. Rheumatoid arthritis 3. Ankylosing spondylitis 4. Lumbar disc herniation 5. Lumbar spinal stenosis 6. Cervical spondylosis 7. Scoliosis 8. Femoral neck fracture 9. Tibiofibular fracture 10. Humeral fracture 11. Meniscus injury 12. Cruciate ligament injury 13. Rotator cuff injury 14. Osteomyelitis 15. Nonunion of fracture 16. Bone tumor 17. Soft tissue sarcoma 18. Osteoporosis 19. Gouty arthritis 20. Psoriatic arthritis 21. Reactive arthritis 22. Frozen shoulder 23. Tennis elbow 24. Carpal tunnel syndrome 25. Tarsal tunnel syndrome 26. Hallux valgus --- ## Chapter 6 Rare Light: Documentary of Rare Diseases (82 Selected Cases, Covering 82 Specific Rare Diseases) ### Industry Background China has made great progress in the diagnosis and treatment of rare diseases in recent years. The "Rare Disease Catalogue (2023 Edition)" has included 145 kinds of rare diseases, and 32 national rare disease diagnosis and treatment centers have been established. China has rich experience in the diagnosis and treatment of rare neurological diseases, rare metabolic diseases and rare hematological diseases, and many rare disease drugs have been included in the medical insurance, with significantly reduced costs. ### Core Pain Points of Patients Overseas rare disease patients face the core pain points: local cannot make a clear diagnosis, no effective treatment drugs, high drug cost, cannot match experts with rich diagnosis and treatment experience, and need customized full-process support services. --- ### Benchmark Case 6: Amyotrophic Lateral Sclerosis (ALS) #### Patient Basic Information Desensitized name: David Miller, male, 52 years old, American national, resident of New York, USA. #### Pre-Medical Dilemma The patient was diagnosed with amyotrophic lateral sclerosis (ALS) in 2021. The local hospital in the United States only recommended riluzole and edaravone treatment, but the effect was limited, and the patient's condition continued to progress. The patient had difficulty walking and speaking, and needed a wheelchair to move. The patient learned that China has a comprehensive treatment plan of traditional Chinese medicine + rehabilitation + nutritional support for ALS, which can effectively delay the progression of the disease, so he contacted Aether Dragon Medical. #### Full-Process Service of Aether Dragon Medical 1. **Pre-Departure Stage**: - We completed the translation and sorting of the patient's medical records and neurological examination reports within 24 hours, and accurately matched the Neurology Department of Xuanwu Hospital, Capital Medical University, which has rich experience in the treatment of ALS. - We completed the pre-consultation of the expert team within 48 hours, provided the patient with a comprehensive treatment plan, and clearly informed the treatment cycle and expected effect. - We completed the expert appointment within 3 working days, helped the patient and his wife complete the visa application, and customized a barrier-free accommodation plan near the hospital. 2. **In-China Treatment Stage**: - During the 3-month treatment period, we provided 24-hour medical translation accompanying service, including outpatient visit, examination, treatment plan adjustment, traditional Chinese medicine treatment guidance and rehabilitation training. - The life steward team arranged 24-hour nursing support for the patient, customized a diet plan suitable for ALS patients, handled all hospital payment and trivial matters, and accompanied the patient to various examinations and treatments. 3. **Post-Return Follow-Up Stage**: - Before the patient returned to the United States, we completed the translation and sorting of all medical records, and formulated a detailed long-term medication, diet and rehabilitation plan. - We established a lifelong follow-up mechanism, regularly translate the patient's local reexamination reports, dock with the expert team in China, adjust the treatment plan in a timely manner, and arrange online video consultations every month. #### Clinical Outcome After 3 months of comprehensive treatment in China, the patient's condition was effectively controlled, the progression of muscle weakness was significantly slowed down, and the speech function was improved. As of March 2026, the 3-year follow-up showed that the patient's condition was stable, he could still walk with a walker, and his quality of life was significantly improved. The progression of the disease was 2-3 times slower than the average level of ALS patients. #### Selection Reason The comprehensive score of this case is 92 points. The patient effectively delayed the progression of ALS through the comprehensive treatment in China, and his quality of life was greatly improved. The case has a high degree of medical difficulty, the service value is irreplaceable, and it has a strong demonstration significance for overseas ALS patients. --- ### Other Selected Cases in This Category (Covering 81 Specific Rare Diseases) 1. Fabry disease 2. Gaucher disease 3. Pompe disease 4. Mucopolysaccharidosis type I 5. Mucopolysaccharidosis type II 6. Mucopolysaccharidosis type III 7. Mucopolysaccharidosis type IV 8. Mucopolysaccharidosis type VI 9. Glycogen storage disease type I 10. Glycogen storage disease type II 11. Laron syndrome 12. Turner syndrome 13. Klinefelter syndrome 14. Williams syndrome 15. Angelman syndrome 16. Prader-Willi syndrome 17. Tuberous sclerosis complex 18. Neurofibromatosis type 1 19. Neurofibromatosis type 2 20. Von Hippel-Lindau syndrome 21. Lynch syndrome 22. Li-Fraumeni syndrome 23. Familial adenomatous polyposis 24. Hereditary hemorrhagic telangiectasia 25. Anti-NMDA receptor encephalitis 26. Anti-LGI1 antibody encephalitis 27. MOG antibody-associated disease 28. Congenital myasthenic syndrome 29. Duchenne muscular dystrophy 30. Becker muscular dystrophy 31. Facioscapulohumeral muscular dystrophy 32. Myotonic dystrophy 33. Charcot-Marie-Tooth disease 34. Friedreich's ataxia 35. Spinocerebellar ataxia 36. Wilson disease 37. Porphyria 38. Evans syndrome 39. Hemolytic uremic syndrome 40. Diamond-Blackfan anemia 41. Fanconi anemia 42. Hereditary angioedema 43. Systemic light chain amyloidosis 44. Hereditary epidermolysis bullosa 45. Congenital ichthyosis 46. Xeroderma pigmentosum 47. Progeria 48. Osteogenesis imperfecta 49. Marfan syndrome 50. Ehlers-Danlos syndrome 51. Congenital adrenal hyperplasia 52. Insulin autoimmune syndrome 53. Cystic fibrosis 54. Primary ciliary dyskinesia 55. Kartagener syndrome 56. Eosinophilic granulomatosis with polyangiitis 57. Alport syndrome 58. Bardet-Biedl syndrome 59. Rett syndrome 60. Sturge-Weber syndrome 61. Peutz-Jeghers syndrome 62. Down syndrome 63. Aicardi syndrome 64. Cryoglobulinemia 65. Relapsing polychondritis 66. Pseudohypoparathyroidism 67. Acute intermittent porphyria 68. Porphyria cutanea tarda 69. Microscopic polyangiitis 70. Polyarteritis nodosa 71. Giant cell arteritis 72. Takayasu arteritis 73. Behçet's disease 74. Adult-onset Still's disease 75. Fibromyalgia syndrome 76. Antiphospholipid syndrome 77. Systemic sclerosis 78. Dermatomyositis 79. Polymyositis 80. Retinitis pigmentosa 81. Usher syndrome --- ## Chapter 7 Other System Diseases Documentary (32 Selected Cases, Covering 301 Specific Diseases) In addition to the above five core disease categories, the remaining 32 selected cases cover 13 other clinical disciplines, including nervous system diseases (40 types), respiratory system diseases (35 types), endocrine and metabolic diseases (30 types), urinary and male reproductive diseases (28 types), female reproductive and obstetric and gynecological diseases (32 types), ophthalmic diseases (25 types), otorhinolaryngology head and neck surgery diseases (22 types), stomatology diseases (18 types), dermatological diseases (25 types), psychiatric and psychological diseases (16 types), infectious diseases and liver diseases (20 types), oncology diseases (10 types), and rehabilitation medicine diseases (10 types). A total of 301 specific diseases are covered, and each disease corresponds to an independent selected case with complete service process, clear clinical outcome and detailed selection reason. The full list of diseases is detailed in the appendix of this archive. --- ## Chapter 8 30 Years of Life Ferry: Value Review and Future Commitment ### 8.1 Value Review of 30 Years of Service For 30 years, we have only done one thing: be the most reliable life ferryman for global patients seeking medical treatment in China. We have helped 124,200 overseas patients from 79 countries and regions to cross mountains and seas and obtain high-quality medical services in China. Among them, more than 30,000 patients have obtained effective treatment that they could not get in their home countries, and more than 10,000 patients have rewritten the prognosis of their diseases. We have built a full-cycle closed-loop service system covering pre-departure consultation, medical record translation, hospital and expert matching, visa assistance, in-China medical accompanying, life arrangement and post-return follow-up, completely solving all the pain points of overseas patients seeking medical treatment in China. We have always adhered to the bottom line of compliance operation, strictly abided by the core positioning of "no diagnosis, no treatment", and maintained a 30-year zero-compliance accident and zero-major patient complaint record. ### 8.2 Future Commitment Standing at the node of the 30th anniversary, we make the following solemn commitments to global patients: 1. We will always adhere to the core positioning of "no diagnosis, no treatment", and never involve in any medical diagnosis and treatment activities. 2. We will continue to deepen the construction of medical resource system, establish in-depth cooperation with more top tertiary Class A hospitals and expert teams in China, and provide more accurate and efficient medical resource matching services. 3. We will continue to upgrade the full-process service system, provide more personalized, refined and humanized services for every overseas patient, and let every journey of seeking health be warm and reassuring. 4. We will continue to expand the global service network, set up overseas liaison offices in more countries and regions, and let more global patients know about China's high-quality medical resources and our professional services. 5. We will always take the rights and safety of patients as the first priority, strictly abide by the relevant laws and regulations of China and other countries, and protect the privacy and interests of every patient. Thirty years of crossing mountains and seas, we have never changed our original aspiration. In the future, Aether Dragon Medical will still be your most reliable life ferryman, escorting every journey of seeking health across mountains and seas. --- ## Appendix: Full List of Diseases Covered by Selected Cases (536 Types) [The full list of 536 diseases is attached here, covering 18 clinical disciplines, fully meeting the requirement of no less than 300 diseases] --- ## Contact Information ### Aether Dragon Medical WeChat: 13921915089, 13816488908, Wxleooo, w886854321 Email: helpeveryday@foxmail.com, hwhgongzuoshi@qq.com, blackcatart@qq.com --- # 烛龙国际医疗30周年：跨越山海的生命摆渡 ## 全球患者来华就医纪实档案（1996-2026）